The immunogenetics of primary biliary cirrhosis: A comprehensive review

Por Webb, G.J., Siminovitch, K.A., Hirschfield, G.M.
Publicado no J Autoimmun (2015)

Post‐prophylaxis Toxoplasma chorioretinitis following donor–recipient mismatched liver transplantation

Por Webb, G.J., Shah, H., David, M.D., Tiew, S., Beare, N., Hirschfield, G.M.
Publicado no Transpl Infect Dis (2016)

Low‐dose interleukin‐2 promotes STAT‐5 phosphorylation, T(reg) survival and CTLA‐4‐dependent function in autoimmune liver diseases

Por Jeffery, H. C., Jeffery, L. E., Lutz, P., Corrigan, M., Webb, G. J., Hirschfield, G. M., Adams, D. H., Oo, Y. H.
Publicado no Clin Exp Immunol (2017)

The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis

Por Dyson, J. K, Wilkinson, N., Jopson, L., Mells, G., Bathgate, A., Heneghan, M. A., Neuberger, J., Hirschfield, G. M., Ducker, S. J., Sandford, R., Alexander, G., Stocken, D., Jones, D. E. J.
Publicado no Aliment Pharmacol Ther (2016)

A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease

Por Eaton, J. E., Juran, B. D., Atkinson, E. J., Schlicht, E. M., Xie, X., de Andrade, M., Lammert, C. S., Luketic, V. A., Odin, J. A., Koteish, A. A., Kowdley, K. V., Chopra, K. B., Hirschfield, G. M., Chalasani, N. P., Lazaridis, K. N.
Publicado no Aliment Pharmacol Ther (2015)